ELISA News and Research

RSS

Are antidrug antibodies reducing the effectiveness of rheumatoid arthritis treatment?

Researchers examined the association between antidrug antibodies and the response to treatments for rheumatoid arthritis.

17 Jul 2023

The prognostic value of PCSK9 levels for predicting major adverse cardiovascular events and mortality in diabetics

Researchers investigate the prognostic value of PCSK9 levels in diabetes patients to predict all-cause mortality and major adverse cardiovascular events.

17 Jul 2023

Boosted immunity: Delta and Omicron-BA.1 infections enhance protection in vaccinated patients

Researchers examined the immune response and potential cross-protection in hospitalized patients with breakthrough infections.

17 Jul 2023

Exploring the relationship between epigenetic aging and gut microbiome composition in physically fit men and women

Researchers investigate the relationship between the gut microbiome, physical fitness, and epigenetic aging in physically fit individuals.

14 Jul 2023

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

Researchers used a K18-hACE2 transgenic (ACE2.Tg) mouse model to demonstrate that interleukin-9 (IL-9).

13 Jul 2023

mAb-based bELISA developed to detect SARS-CoV-2 antibodies in a broad spectrum of animal species

Researchers developed a mAb-based blocking enzyme-linked immunosorbent assay (bELISA) to detect SARS-CoV-2 in animals.

11 Jul 2023

Novel vaccine against Lyme disease reported to be safe and effective

Researchers determine the safety and immunogenicity of a novel candidate vaccine against Lyme borreliosis.

11 Jul 2023

Prolonged T-cell response during severe COVID-19 does not contribute to long COVID

Persistent immune activation and elevated cytokine levels were observed in patients with severe COVID-19, even months after recovery. However, the correlation between immune activation and long COVID symptoms appeared to be independent, suggesting other factors influencing disease severity.

9 Jul 2023

Scientists develop cross-species coronavirus test

In an advance that will help scientists track coronavirus variants in wild and domesticated animals, researchers report they can now detect exposure to the SARS-CoV-2 virus in any animal species.

6 Jul 2023

Unlocking the immune puzzle: study evaluates the immune impact of second booster COVID-19 vaccine

Researchers assessed acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant of concern (VOC).

6 Jul 2023

Rising incidence of kiwifruit allergy in children: study highlights severe allergic reactions

Study aimed to compile Kiwifruit allergy recognition patterns to enhance patient management and clinical practice.

6 Jul 2023

A novel RSV vaccine that could be effective across all ages

Researchers evaluate the in vivo efficacy of a respiratory syncytial virus vaccine in old and young rats.

4 Jul 2023

Resistance training could be a simple and affordable therapy for Alzheimer's patients

Regular physical exercise, such as resistance training, can prevent Alzheimer's disease, or at least delay the appearance of symptoms, and serves as a simple and affordable therapy for Alzheimer's patients.

3 Jul 2023

COVID-19 severity linked to autoantibodies against blood clotting protein

Study investigates the occurrence of ADAMTS13 antibodies in COVID-19 patients and their association with disease severity and lower ADAMTS13 activity. The findings suggest the need to include ADAMTS13 antibodies in diagnosing and managing SARS-CoV-2 infections.

2 Jul 2023

Towards Zika preparedness: immunogenicity insights from vaccine research

Study assesses the safety and immunogenicity of an inactivated Zika virus vaccine candidate.

30 Jun 2023

Advances in influenza research

This interview with Dr. Mohammad S Safiarian, Associate Product Manager at Sino Biological, discusses the advances in influenza research and how effective vaccines are developed.

From Sino Biological Inc. 30 Jun 2023

New atlas offers a way to identify the deep mechanisms of cancer

An atlas that catalogs gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer, according to researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.

29 Jun 2023

ELISA News and Research

Are antidrug antibodies reducing the effectiveness of rheumatoid arthritis treatment?

The prognostic value of PCSK9 levels for predicting major adverse cardiovascular events and mortality in diabetics

Boosted immunity: Delta and Omicron-BA.1 infections enhance protection in vaccinated patients

Exploring the relationship between epigenetic aging and gut microbiome composition in physically fit men and women

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

mAb-based bELISA developed to detect SARS-CoV-2 antibodies in a broad spectrum of animal species

Novel vaccine against Lyme disease reported to be safe and effective

Prolonged T-cell response during severe COVID-19 does not contribute to long COVID

Scientists develop cross-species coronavirus test

Unlocking the immune puzzle: study evaluates the immune impact of second booster COVID-19 vaccine

Rising incidence of kiwifruit allergy in children: study highlights severe allergic reactions

A novel RSV vaccine that could be effective across all ages

Resistance training could be a simple and affordable therapy for Alzheimer's patients

COVID-19 severity linked to autoantibodies against blood clotting protein

Towards Zika preparedness: immunogenicity insights from vaccine research

Advances in influenza research

New atlas offers a way to identify the deep mechanisms of cancer

Lonely people process the world differently, study finds

New research shows antibody cross-reactivity between human and animal coronaviruses

Advocates call for 911 changes. Police have mixed feelings.

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News